Tag Archives: Pharmaceutical

Medical papers. How ghostly is ghostwriting?

by Xavier Tello Yesterday, the New York Times published an article commenting on of the discovery of a new case of ghostwriting, apparently paid by Wyeth for papers published between 1998 and 2005. The title: “Medical Papers by Ghostwriters Pushed … Continue reading

Posted in Casos de Estudio, Opinión, Salud | Tagged , , , , , , , , , , , , , , , , | 8 Comments

P&G will sell its Pharmaceutical Unit

According to financial-specialized media, P&G is seriously considering to sell its pharmaceutical unit. This are the first confirmed news of the American consumer company about letting this important branch go, despite 2006 and last year’s news of cutting its R&D … Continue reading

Posted in Alta Dirección, Mercadotecnia, Planeac. Estratégica, Salud, Ventas | Tagged , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Regulación y Ética en el trabajo de los Representantes Médicos

El pasado 19 de enero, se publicó en REFORMA un artículo de Sara Cantera intitulado: “Regulan Visitas de los Laboratorios”. En esta pieza, en la que tuvimos el gusto de colaborar, se hace referencia a dos nuevas disposiciones para la … Continue reading

Posted in Alta Dirección, Mercadotecnia, Planeac. Estratégica, Salud, Ventas | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | 1 Comment